We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
+$34.5M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.95%
Holding
1,364
New
25
Increased
674
Reduced
255
Closed
34

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$233M
2
WPC icon
W.P. Carey
WPC
+$93M
3
EXR icon
Extra Space Storage
EXR
+$81.4M
4
IRM icon
Iron Mountain
IRM
+$41.1M
5
EGP icon
EastGroup Properties
EGP
+$39.7M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$154M
2
KRMA
Global X Conscious Companies ETF
KRMA
+$114M
3
CUZ icon
Cousins Properties
CUZ
+$106M
4
FR icon
First Industrial Realty Trust
FR
+$66.7M
5
PSA icon
Public Storage
PSA
+$53.2M

Sector Composition

Rank Sector Weight
1 Real Estate 53.25%
2 Technology 12.67%
3 Healthcare 4.74%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GERN icon
1176
Geron
GERN
$930M
$3K ﹤0.01%
1,407
– –
HCM icon
1177
HUTCHMED
HCM
$1.93B
$3K ﹤0.01%
185
– –
IBRX icon
1178
ImmunityBio
IBRX
$7.3B
$3K ﹤0.01%
1,610
– –
INVA icon
1179
Innoviva
INVA
$1.61B
$3K ﹤0.01%
260
– –
KYMR icon
1180
Kymera Therapeutics
KYMR
$8.73B
$3K ﹤0.01%
221
– –
PLRX icon
1181
Pliant Therapeutics
PLRX
$66.3M
$3K ﹤0.01%
196
– –
PTGX icon
1182
Protagonist Therapeutics
PTGX
$8.8B
$3K ﹤0.01%
163
– –
REPL icon
1183
Replimune Group
REPL
$449M
$3K ﹤0.01%
200
– –
SANA icon
1184
Sana Biotechnology
SANA
$916M
$3K ﹤0.01%
767
– –
DCPH
1185
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3K ﹤0.01%
272
– –
ICPT
1186
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3K ﹤0.01%
167
– –
INBX
1187
DELISTED
Inhibrx, Inc. Common Stock
INBX
$3K ﹤0.01%
175
– –
ACRS icon
1188
Aclaris Therapeutics
ACRS
$744M
$2K ﹤0.01%
248
– –
ALEC icon
1189
Alector
ALEC
$169M
$2K ﹤0.01%
277
– –
ANAB icon
1190
AnaptysBio
ANAB
$1.54B
$2K ﹤0.01%
105
– –
ARCT icon
1191
Arcturus Therapeutics
ARCT
$163M
$2K ﹤0.01%
90
– –
AVXL icon
1192
Anavex Life Sciences
AVXL
$238M
$2K ﹤0.01%
314
– –
BCYC
1193
Bicycle Therapeutics
BCYC
$275M
$2K ﹤0.01%
103
– –
BNS icon
1194
Scotiabank
BNS
$108B
$2K ﹤0.01%
50
– –
DYN icon
1195
Dyne Therapeutics
DYN
$4.28B
$2K ﹤0.01%
210
– –
LKFT
1196
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$2K ﹤0.01%
51
– –
HLVX
1197
DELISTED
HilleVax
HLVX
$2K ﹤0.01%
134
– –
HROW icon
1198
Harrow
HROW
$1.47B
$2K ﹤0.01%
110
– –
KNSA icon
1199
Kiniksa Pharmaceuticals
KNSA
$6.11B
$2K ﹤0.01%
139
– –
KURA icon
1200
Kura Oncology
KURA
$826M
$2K ﹤0.01%
227
– –
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2023 Portfolio in Review

As of Q3 2023, Daiwa Securities Group held 1,364 positions worth $14B, down 7.2% from $15.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.3%. Daiwa Securities Group opened 25 new positions and exited 34, leaving the 1,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2023 buy was Kenvue: 139,472 shares worth $2.8M.
  • Daiwa Securities Group added most to American Tower in Q3 2023, an estimated $233M increase.
  • Daiwa Securities Group's biggest Q3 2023 reduction was Digital Realty Trust, cutting an estimated $154M.
  • Daiwa Securities Group fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $5.38M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $14B portfolio in Q3 2023.
  • Daiwa Securities Group opened 25 new positions and closed 34 in Q3 2023.
  • Daiwa Securities Group's portfolio value fell 7.2% quarter-over-quarter to $14B.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.